Xpert C. Difficle/Epi Assay
C. Difficile Nucleic Acid Amplification Test Assay. 510(k) K110203, from Cepheid (Sunnyvale, CA). Product code OMN, class 1.
As of Nov 20, 2026, K110203 is an FDA 510(k) held by Cepheid, substantially equivalent on Apr 7, 2011 after 73 days, with no recalls tied to it in FDA's recall database.
- Review time: 73 days
- Recalls: 0
- Cited as a predicate by: 1 device
The Cepheid Xpert® C. difficile/Epi Assay is a qualitative in vitro diagnostic test for rapid detection of toxin B gene sequences and for presumptive identification of 027/NAP1/BI strains of toxigenic Clostridium difficile from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI). Presumptive identification of 027/NAP1/BI strains of C.
- BD Geneohm Cdiff AssayK081920 · Bd Diagnostics (Geneohm Sciences, Inc.) · Dec 19, 2008
- Xpert C. DifficileK091109 · Cepheid · Jul 9, 2009
- Verigene C. Difficile Nucleic Acid Test (Cdf)K123197 · Nanosphere, Inc. · Dec 5, 2012
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jan 24, 2011
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.2660
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files